Site search
2811 results for '' found
An ALLG Phase 2 study to Investigate Novel Triplets to Extend Remission with VENetoclax in Elderly (INTERVENE) Acute Myeloid Leukaemia (ACTRN12619001655134)
An ALLG Phase 2 study to Investigate Novel Triplets to Extend Remission with VENetoclax in Elderly (INTERVENE) Acute Myeloid Leukaemia (ACTRN12619001655134)
/research/clinical-trials/alfred-clinical-trials/an-allg-phase-2-study-to-investigate-novel-triplets-to-extend-remission-with-venetoclax-in-elderly-intervene-acute-myeloid-leukaemia-actrn12619001655134
A phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of AL002 in participants with Early Alzheimer’s disease (NCT04592874)
A phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of AL002 in participants with Early Alzheimer’s disease (NCT04592874)
/research/clinical-trials/alfred-clinical-trials/a-phase-2-randomized-double-blind-placebo-controlled-multicenter-study-to-evaluate-the-efficacy-and-safety-of-al002-in-participants-with-early-alzheimers-diseasenct04592874
A multicentre, multinational, cohort long-term post-market Clinical [PMCF] follow-up of the safety and efficacy of the Osseo anchored Prostheses for the Rehabilitation of Amputees [OPRA] implant
A multicentre, multinational, cohort long-term post-market Clinical [PMCF] follow-up of the safety and efficacy of the Osseo anchored Prostheses for the Rehabilitation of Amputees [OPRA] implant
/research/clinical-trials/alfred-clinical-trials/a-multicentre-multinational-cohort-long-term-post-market-clinical-pmcf-follow-up-of-the-safety-and-efficacy-of-the-osseo-anchored-prostheses-for-the-rehabilitation-of-amputees-opra-implant
AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial (ACTRN1262100043
AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial (ACTRN1262100043
/research/clinical-trials/alfred-clinical-trials/amlm26-intercept-investigating-novel-therapy-to-target-early-relapse-and-clonal-evolution-as-pre-emptive-therapy-in-aml-a-multi-arm-precision-based-recursive-platform-trial-actrn1262100043
Intensive nutrition therapy compared to usual care in critically ill adults: A randomised pilot trial (NCT03292237)
Intensive nutrition therapy compared to usual care in critically ill adults: A randomised pilot trial (NCT03292237)
/research/clinical-trials/alfred-clinical-trials/intensive-nutrition-therapy-compared-to-usual-care-in-critically-ill-adults-a-randomised-pilot-trial-nct03292237
A Phase 1 Randomised, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of INI-822 In Healthy Volunteers And Pa
A Phase 1 Randomised, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of INI-822 In Healthy Volunteers And Pa
/research/clinical-trials/alfred-clinical-trials/a-phase-1-randomised-double-blind-placebo-controlled-single-and-multiple-ascending-dose-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ini-822-in-healthy-volunteers-and-pa
Invasive assessment of pulmonary microvascular function with novel indices of pulmonary flow reserve and pulmonary microcirculatory resistance. (Trial Not Registered)
Invasive assessment of pulmonary microvascular function with novel indices of pulmonary flow reserve and pulmonary microcirculatory resistance. (Trial Not Registered)
/research/clinical-trials/alfred-clinical-trials/invasive-assessment-of-pulmonary-microvascular-function-with-novel-indices-of-pulmonary-flow-reserve-and-pulmonary-microcirculatory-resistance-trial-not-registered
An International, Phase 3, Randomized, Multicenter, Open label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring K
An International, Phase 3, Randomized, Multicenter, Open label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring K
/research/clinical-trials/alfred-clinical-trials/an-international-phase-3-randomized-multicenter-open-label-study-of-ripretinib-vs-sunitinib-in-patients-with-advanced-gastrointestinal-stromal-tumor-gist-with-kit-exon-11-and-co-occurring-k
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, ADAPTIVE PHASE III TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF VILOBELIMAB IN THE TREATMENT OF ULCERATIVE PYODERMA GANGRENOSUM (NCT059
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, ADAPTIVE PHASE III TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF VILOBELIMAB IN THE TREATMENT OF ULCERATIVE PYODERMA GANGRENOSUM (NCT059
/research/clinical-trials/alfred-clinical-trials/a-randomized-double-blind-placebo-controlled-multicenter-adaptive-phase-iii-trial-to-investigate-efficacy-and-safety-of-vilobelimab-in-the-treatment-of-ulcerative-pyoderma-gangrenosum-nct059
A Phase III Randomised Crossover Trial to Assess Feasibility of Domiciliary Nasal High Flow for Chronic Breathlessness in People with Interstitial Lung Disease (ACTRN12623000835640p)
A Phase III Randomised Crossover Trial to Assess Feasibility of Domiciliary Nasal High Flow for Chronic Breathlessness in People with Interstitial Lung Disease (ACTRN12623000835640p)
/research/clinical-trials/alfred-clinical-trials/a-phase-iii-randomised-crossover-trial-to-assess-feasibility-of-domiciliary-nasal-high-flow-for-chronic-breathlessness-in-people-with-interstitial-lung-disease-actrn12623000835640p